Acute Coronary Syndrome, Anemia, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Diarrhea, Fatigue, General Check-up, Gout, Hypertension, Liver Diseases, Lung Embolism, Medication Monitoring, Obesity, Rheumatoid Arthritis, Sexually Transmitted Diseases, Thyroid Diseases
Conditions
Keywords
order sets, decision support, laboratory test, primary care
Brief summary
Cluster randomised controlled trial to evaluate what the effect is of evidence-based order sets aimed at five indications on the appropriateness of laboratory test ordering in primary care.
Detailed description
Cluster randomised controlled trial in Belgian primary care practices. Participants will be primary care physicians working in primary care practices affiliated to one of three collaborating laboratories in the Leuven, Ghent or Antwerp regions. Primary care practices will be allocated and randomized to either the intervention or control group. Physicians in PCPs randomized to the intervention will be offered order sets based on indication when using the CPOE for ordering laboratory tests. The effect of order sets will be analyzed for 17 common indications for ordering laboratory tests in Belgian primary care: diabetes mellitus, hypertension, cardiovascular disease, general check-up, unexplained fatigue, anemia, liver pathology, medication monitoring, gout, chronic kidney disease, lung embolism, acute coronary syndrome, diarrhea, thyroid disease, sexually transmitted disease, rheumatoid arthritis and obesity.
Interventions
CPOE including series of recommended tests ordered per indication
CPOE only
Sponsors
Study design
Eligibility
Inclusion criteria
* Primary care practices will be considered eligible if all the physicians active in the practice agree to be involved in the study * All family physicians will be considered eligible if they: * Collaborate with either MCH, Anacura or AML for their laboratory test orders * Agree to use the online CPOE for their laboratory test orders * Use a computerized EHR for patient care * Agree to the terms in the informed consent
Exclusion criteria
* Primary care practices where one or more physicians refuse to be enrolled will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Appropriateness | 3 months | number of appropriate tests for 17 study indications |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Missed or delayed diagnoses | 1 year | Incidence of missed or delayed diagnoses after laboratory test |
| Laboratory test volume | 1 year | Total volume of ordered laboratory tests |
Other
| Measure | Time frame | Description |
|---|---|---|
| Downstream or cascade clinical activities | 1 year | All downstream or cascade clinical activities as a result of abnormal test result |
Countries
Belgium